126 related articles for article (PubMed ID: 10747968)
1. Effects of incorporation of immunoglobulin G and complement component C1q on uptake and degradation of Alzheimer's disease amyloid fibrils by microglia.
Brazil MI; Chung H; Maxfield FR
J Biol Chem; 2000 Jun; 275(22):16941-7. PubMed ID: 10747968
[TBL] [Abstract][Full Text] [Related]
2. Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells.
Chung H; Brazil MI; Soe TT; Maxfield FR
J Biol Chem; 1999 Nov; 274(45):32301-8. PubMed ID: 10542270
[TBL] [Abstract][Full Text] [Related]
3. Antibody-mediated phagocytosis of the amyloid beta-peptide in microglia is differentially modulated by C1q.
Webster SD; Galvan MD; Ferran E; Garzon-Rodriguez W; Glabe CG; Tenner AJ
J Immunol; 2001 Jun; 166(12):7496-503. PubMed ID: 11390503
[TBL] [Abstract][Full Text] [Related]
4. Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells.
Paresce DM; Chung H; Maxfield FR
J Biol Chem; 1997 Nov; 272(46):29390-7. PubMed ID: 9361021
[TBL] [Abstract][Full Text] [Related]
5. Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils.
Majumdar A; Cruz D; Asamoah N; Buxbaum A; Sohar I; Lobel P; Maxfield FR
Mol Biol Cell; 2007 Apr; 18(4):1490-6. PubMed ID: 17314396
[TBL] [Abstract][Full Text] [Related]
6. Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar Aβ by microglia.
Fu H; Liu B; Frost JL; Hong S; Jin M; Ostaszewski B; Shankar GM; Costantino IM; Carroll MC; Mayadas TN; Lemere CA
Glia; 2012 May; 60(6):993-1003. PubMed ID: 22438044
[TBL] [Abstract][Full Text] [Related]
7. Deacetylation of TFEB promotes fibrillar Aβ degradation by upregulating lysosomal biogenesis in microglia.
Bao J; Zheng L; Zhang Q; Li X; Zhang X; Li Z; Bai X; Zhang Z; Huo W; Zhao X; Shang S; Wang Q; Zhang C; Ji J
Protein Cell; 2016 Jun; 7(6):417-33. PubMed ID: 27209302
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer's pathology.
Gebril HM; Aryasomayajula A; de Lima MRN; Uhrich KE; Moghe PV
Transl Neurodegener; 2024 Jan; 13(1):2. PubMed ID: 38173014
[TBL] [Abstract][Full Text] [Related]
9. Degradation of fibrillar forms of Alzheimer's amyloid beta-peptide by macrophages.
Majumdar A; Chung H; Dolios G; Wang R; Asamoah N; Lobel P; Maxfield FR
Neurobiol Aging; 2008 May; 29(5):707-15. PubMed ID: 17222479
[TBL] [Abstract][Full Text] [Related]
10. Degradation of Alzheimer's amyloid fibrils by microglia requires delivery of ClC-7 to lysosomes.
Majumdar A; Capetillo-Zarate E; Cruz D; Gouras GK; Maxfield FR
Mol Biol Cell; 2011 May; 22(10):1664-76. PubMed ID: 21441306
[TBL] [Abstract][Full Text] [Related]
11. C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-β neurotoxicity.
Benoit ME; Hernandez MX; Dinh ML; Benavente F; Vasquez O; Tenner AJ
J Biol Chem; 2013 Jan; 288(1):654-65. PubMed ID: 23150673
[TBL] [Abstract][Full Text] [Related]
12. Complement component C1q modulates the phagocytosis of Abeta by microglia.
Webster SD; Yang AJ; Margol L; Garzon-Rodriguez W; Glabe CG; Tenner AJ
Exp Neurol; 2000 Jan; 161(1):127-38. PubMed ID: 10683279
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics in Alzheimer's disease model rats of a bifunctional peptide with the potential to accelerate the degradation and reduce the toxicity of amyloid β-Cu fibrils.
Wang D; Zhang Q; Hu X; Wang W; Zhu X; Yuan Z
Acta Biomater; 2018 Jan; 65():327-338. PubMed ID: 29111371
[TBL] [Abstract][Full Text] [Related]
14. Differential pathways for interleukin-1β production activated by chromogranin A and amyloid β in microglia.
Wu Z; Sun L; Hashioka S; Yu S; Schwab C; Okada R; Hayashi Y; McGeer PL; Nakanishi H
Neurobiol Aging; 2013 Dec; 34(12):2715-25. PubMed ID: 23831373
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunization.
Zotova E; Bharambe V; Cheaveau M; Morgan W; Holmes C; Harris S; Neal JW; Love S; Nicoll JA; Boche D
Brain; 2013 Sep; 136(Pt 9):2677-96. PubMed ID: 23943781
[TBL] [Abstract][Full Text] [Related]
16. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
[TBL] [Abstract][Full Text] [Related]
17. Desacyl-ghrelin and synthetic GH-secretagogues modulate the production of inflammatory cytokines in mouse microglia cells stimulated by beta-amyloid fibrils.
Bulgarelli I; Tamiazzo L; Bresciani E; Rapetti D; Caporali S; Lattuada D; Locatelli V; Torsello A
J Neurosci Res; 2009 Sep; 87(12):2718-27. PubMed ID: 19382238
[TBL] [Abstract][Full Text] [Related]
18. TLQP-21 mediated activation of microglial BV2 cells promotes clearance of extracellular fibril amyloid-β.
Cho K; Jang YJ; Lee SJ; Jeon YN; Shim YL; Lee JY; Lim DS; Kim DH; Yoon SY
Biochem Biophys Res Commun; 2020 Apr; 524(3):764-771. PubMed ID: 32037089
[TBL] [Abstract][Full Text] [Related]
19. Localization and cell association of C1q in Alzheimer's disease brain.
Afagh A; Cummings BJ; Cribbs DH; Cotman CW; Tenner AJ
Exp Neurol; 1996 Mar; 138(1):22-32. PubMed ID: 8593893
[TBL] [Abstract][Full Text] [Related]
20. Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism.
Koenigsknecht J; Landreth G
J Neurosci; 2004 Nov; 24(44):9838-46. PubMed ID: 15525768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
